DenovAI Biotech vs Scala Biodesign

DenovAI Biotech vs Scala Biodesign, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: DenovAI Biotech is on 27/100 and Scala Biodesign on 56/100.

DenovAI Biotech logo
DenovAI BiotechDenovAI Biotech leverages AI for de novo protein design, focusing on novel therapeutics and diagnostics.
Try DenovAI Biotech
Scala Biodesign logo
Scala BiodesignDesigns proteins with superior properties using computational analysis, evolutionary insights, and AI.
Try Scala Biodesign

Where each one leads

DenovAI Biotech

  • headcount growth: +123.5% against +49.4%

Scala Biodesign

  • our overall score: 56/100 against 27/100
  • agent readiness: 45/100 against 29/100
  • domain rating: 23/100 against 8/100
  • headcount: 30 against 11
  • LinkedIn following: 5,945 against 1,367

At a glance

MeasureDenovAI BiotechScala Biodesign
What it isDenovAI Biotech leverages AI for de novo protein design, focusing on novel therapeutics and diagnostics.Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.
CategoryLife Sciences, Biotech, Drug Discovery, AI-Driven Protein DesignLife Sciences, Biotech, Protein, AI-Driven Protein Design
Sells toBusiness modelB2BB2B
OfferingPlatformSoftware
Founded20232021
HeadquartersRehovot, IsraelTel Aviv, Israel
StatusActiveActive

Size, funding and growth

MeasureDenovAI BiotechScala Biodesign
Employees1130
Headcount growthLast 12 months+123.5%+49.4%
Total fundingNot published$21.5M
Latest roundSeedSeries A
LinkedIn followers1,3675,945

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureDenovAI BiotechScala Biodesign
StartupHub scoreOur 0-100 rating27/10056/100
Traction11/10052/100
Team30/10070/100
Search visibility36/10034/100
QualityNot published58/100
Agent readinessHow well an AI agent can read and act on the siteF (29/100)D (45/100)
Domain ratingLink authority, 0-1008/10023/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureDenovAI BiotechScala Biodesign
CMSNot detectedWix
AnalyticsNot detectedLinkedin Insight
Open sourceYesYes

DenovAI Biotech vs Scala Biodesign: common questions

Which is better, DenovAI Biotech or Scala Biodesign?

On our 0-100 score Scala Biodesign rates higher (56/100 against 27/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.

How do DenovAI Biotech and Scala Biodesign compare on the numbers?

DenovAI Biotech leads on headcount growth (+123.5% against +49.4%). Scala Biodesign leads on our overall score (56/100 against 27/100), agent readiness (45/100 against 29/100), domain rating (23/100 against 8/100), headcount (30 against 11), LinkedIn following (5,945 against 1,367).

Read the full DenovAI Biotech review and pricing or the Scala Biodesign review and pricing. You can also browse other DenovAI Biotech alternatives we track.